U.S. Markets closed
  • S&P Futures

    4,239.50
    +8.00 (+0.19%)
     
  • Dow Futures

    33,838.00
    +79.00 (+0.23%)
     
  • Nasdaq Futures

    14,293.00
    +30.00 (+0.21%)
     
  • Russell 2000 Futures

    2,306.90
    +6.60 (+0.29%)
     
  • Crude Oil

    73.13
    +0.05 (+0.07%)
     
  • Gold

    1,778.30
    -5.10 (-0.29%)
     
  • Silver

    25.94
    -0.17 (-0.64%)
     
  • EUR/USD

    1.1936
    +0.0003 (+0.0239%)
     
  • 10-Yr Bond

    1.4870
    +0.0150 (+1.02%)
     
  • Vix

    16.32
    -0.34 (-2.04%)
     
  • GBP/USD

    1.3951
    -0.0013 (-0.0921%)
     
  • USD/JPY

    111.0300
    +0.0680 (+0.0613%)
     
  • BTC-USD

    33,333.12
    -725.50 (-2.13%)
     
  • CMC Crypto 200

    800.67
    -9.52 (-1.17%)
     
  • FTSE 100

    7,074.06
    -15.95 (-0.22%)
     
  • Nikkei 225

    28,886.38
    +11.49 (+0.04%)
     

Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug

·2 min read
Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

AbCellera stock tumbled Friday, despite in-line royalties for its Lilly-partnered Covid drug. Here's why the stock toppled.